PBH
Prestige Consumer Healthcare Inc.
NYSE · Healthcare · Medical - Distribution · US
$52.26
−0.57%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B |
| Cost of Revenue | 516.4M | 514.1M | 503.3M | 500.9M | 502.4M |
| Gross Profit | 588.5M | 574.6M | 634.5M | 624.4M | 625.3M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 279.8M | 265.2M | 263.9M | 259.5M | 252.4M |
| General & Admin Expense | 131.3M | 116.4M | 108.2M | 106.2M | 107.4M |
| Selling & Marketing Expense | 148.5M | 148.8M | 155.7M | 153.3M | 145.1M |
| Other Expenses | 18.5M | — | 33.8M | 22.6M | 395.3M |
| Total Operating Expenses | 298.3M | 265.2M | 297.7M | 282.0M | 647.7M |
| Cost and Expenses | 814.7M | 779.3M | 801.0M | 782.9M | 1.2B |
| Operating Income (EBIT) | 290.2M | 309.4M | 336.8M | 342.4M | (22.4M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 46.1M | 42.3M | 47.6M | 67.2M | 69.2M |
| Net Interest Income | (46.1M) | (42.3M) | (47.6M) | (67.2M) | (69.2M) |
| Other Non-Op Income/Expense | (55.9M) | (51.9M) | (52.6M) | (66.4M) | (71.5M) |
| Non-Operating Income (excl Interest) | 9.8M | 9.6M | 5.0M | (756.0K) | 2.3M |
| EBT (Pre-Tax Income) | 234.3M | 257.5M | 284.2M | 276.0M | (93.9M) |
| Income Tax Expense | 62.2M | 67.2M | 69.6M | 66.7M | (11.6M) |
| Bottom Line | |||||
| Net Income | 172.0M | 190.3M | 214.6M | 209.3M | (82.3M) |
| Earnings from Cont. Ops | 172.0M | 190.3M | 214.6M | 209.3M | (82.3M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 172.0M | 190.3M | 214.6M | 209.3M | (82.3M) |
| Per Share | |||||
| Basic EPS | $3.59 | $3.93 | $4.32 | $4.21 | ($1.65) |
| Diluted EPS | $3.57 | $3.91 | $4.29 | $4.17 | ($1.65) |
| Revenue Per Share | $23.28 | $22.47 | $22.89 | $22.62 | $22.61 |
| Shares | |||||
| Basic Shares Outstanding | 47.5M | 48.5M | 49.7M | 49.8M | 49.9M |
| Diluted Shares Outstanding | 47.6M | 48.7M | 50.1M | 50.2M | 49.9M |
| Profitability Metrics | |||||
| EBITDA | 312.7M | 331.1M | 362.0M | 373.9M | 7.9M |
| D&A | 32.4M | 31.3M | 30.2M | 30.7M | 32.6M |
| EBIT | 280.3M | 299.8M | 331.8M | 343.2M | (24.8M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026